These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34358264)
1. Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression. Gim JA; Bang SM; Lee YS; Lee Y; Yim SY; Jung YK; Kim H; Kim BH; Kim JH; Seo YS; Yim HJ; Yeon JE; Um SH; Byun KS PLoS One; 2021; 16(8):e0255822. PubMed ID: 34358264 [TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. Li YJ; Baumert BO; Stratakis N; Goodrich JA; Wu HT; He JX; Zhao YQ; Aung MT; Wang HX; Eckel SP; Walker DI; Valvi D; La Merrill MA; Ryder JR; Inge TH; Jenkins T; Sisley S; Kohli R; Xanthakos SA; Baccarelli AA; McConnell R; Conti DV; Chatzi L World J Gastroenterol; 2024 Jan; 30(4):332-345. PubMed ID: 38313232 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. Tan Y; Ge G; Pan T; Wen D; Gan J PLoS One; 2014; 9(8):e105192. PubMed ID: 25141008 [TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316 [TBL] [Abstract][Full Text] [Related]
6. microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver. Zhang JW; Pan HT Genes Genomics; 2022 Jul; 44(7):879-888. PubMed ID: 34390467 [TBL] [Abstract][Full Text] [Related]
8. [Serum exosomal miRNAs profiling and functional study in patients with non-alcoholic fatty liver disease]. Zhang S; Liu YD; He ZD; Liu B; Linghu EQ Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):987-994. PubMed ID: 34814394 [No Abstract] [Full Text] [Related]
10. Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization. Chalasani N; Toden S; Sninsky JJ; Rava RP; Braun JV; Gawrieh S; Zhuang J; Nerenberg M; Quake SR; Maddala T Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G439-G449. PubMed ID: 33501884 [TBL] [Abstract][Full Text] [Related]
11. The role of exosomal miRNA in nonalcoholic fatty liver disease. Mahmoudi A; Butler AE; Jamialahmadi T; Sahebkar A J Cell Physiol; 2022 Apr; 237(4):2078-2094. PubMed ID: 35137416 [TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression. Cheng L; Yu P; Li F; Jiang X; Jiao X; Shen Y; Lai X Hum Cell; 2021 Nov; 34(6):1697-1708. PubMed ID: 34410623 [TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD. Zhu M; Wang Q; Zhou W; Liu T; Yang L; Zheng P; Zhang L; Ji G Sci Rep; 2018 May; 8(1):7628. PubMed ID: 29769539 [TBL] [Abstract][Full Text] [Related]
14. Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease. Kim TH; Lee Y; Lee YS; Gim JA; Ko E; Yim SY; Jung YK; Kang S; Kim MY; Kim H; Kim BH; Kim JH; Seo YS; Yim HJ; Yeon JE; Um SH; Byun KS Sci Rep; 2021 Jul; 11(1):14639. PubMed ID: 34282172 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease. Jiang H; Qian Y; Shen Z; Liu Y; He Y; Gao R; Shen M; Chen S; Fu Q; Yang T Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955511 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives. Hochreuter MY; Dall M; Treebak JT; Barrès R Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120 [TBL] [Abstract][Full Text] [Related]
17. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients. Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434 [TBL] [Abstract][Full Text] [Related]
18. Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity. Di Mauro S; Scamporrino A; Petta S; Urbano F; Filippello A; Ragusa M; Di Martino MT; Scionti F; Grimaudo S; Pipitone RM; Privitera G; Di Pino A; Scicali R; Valenti L; Dongiovanni P; Fracanzani A; Rabuazzo AM; Craxì A; Purrello M; Purrello F; Piro S Liver Int; 2019 Sep; 39(9):1742-1754. PubMed ID: 31169972 [TBL] [Abstract][Full Text] [Related]